SEC Form 4 · accession 0001437749-17-009691
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Molly Hemmeter
Officer — Chief Executive Officer
Period of report
May 18, 2017
Accepted (ET)
May 19, 2017 · 6:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 18, 2017 | M | 20,786 | $5.63 | A | 41,199 | D | |
| Common Stock | May 18, 2017 | F | 8,798 | $13.30 | D | 32,401 | D | |
| Common Stock | May 18, 2017 | M | 16,714 | $5.63 | A | 49,115 | D | |
| Common Stock | May 18, 2017 | F | 10,697 | $13.30 | D | 38,418 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy) | $5.63 | May 18, 2017 | M | 20,786 | D | Jun 26, 2010 | May 26, 2017 | Common Stock | 20,786 | 496,714 | D |
| Nonqualified Stock Options (Right to Buy) | $5.63 | May 18, 2017 | M | 16,714 | D | Jun 26, 2010 | May 26, 2017 | Common Stock | 16,714 | 480,000 | D |